KR920016423A - 루코트리엔 길항제로서의 퀴놀린-함유 케토산 - Google Patents
루코트리엔 길항제로서의 퀴놀린-함유 케토산 Download PDFInfo
- Publication number
- KR920016423A KR920016423A KR1019920002536A KR920002536A KR920016423A KR 920016423 A KR920016423 A KR 920016423A KR 1019920002536 A KR1019920002536 A KR 1019920002536A KR 920002536 A KR920002536 A KR 920002536A KR 920016423 A KR920016423 A KR 920016423A
- Authority
- KR
- South Korea
- Prior art keywords
- mammal
- compound
- effective amount
- antagonists
- administering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65893191A | 1991-02-21 | 1991-02-21 | |
| US07/658,931 | 1991-02-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR920016423A true KR920016423A (ko) | 1992-09-24 |
Family
ID=24643302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920002536A KR920016423A (ko) | 1991-02-21 | 1992-02-20 | 루코트리엔 길항제로서의 퀴놀린-함유 케토산 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0500360B1 (hu) |
| JP (1) | JPH0788361B2 (hu) |
| KR (1) | KR920016423A (hu) |
| CN (1) | CN1065062A (hu) |
| AT (1) | ATE154801T1 (hu) |
| AU (1) | AU648385B2 (hu) |
| CA (1) | CA2061675C (hu) |
| CS (1) | CS47192A3 (hu) |
| DE (1) | DE69220517T2 (hu) |
| ES (1) | ES2104821T3 (hu) |
| FI (1) | FI920734A (hu) |
| HU (1) | HU9200552D0 (hu) |
| IE (1) | IE920499A1 (hu) |
| IL (1) | IL100985A0 (hu) |
| MX (1) | MX9200714A (hu) |
| NO (1) | NO920681L (hu) |
| ZA (1) | ZA921232B (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5270324A (en) * | 1992-04-10 | 1993-12-14 | Merck Frosst Canada, Inc. | Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists |
| GB9216768D0 (en) * | 1992-08-07 | 1992-09-23 | Leo Pharm Prod Ltd | Chemical compounds |
| EP0830133A1 (en) * | 1995-04-28 | 1998-03-25 | Takeda Chemical Industries, Ltd. | Therapeutic composition for arthritis |
| WO1998008820A1 (fr) * | 1996-08-26 | 1998-03-05 | Yamanouchi Pharmaceutical Co., Ltd. | Composes de benzenesulfone et sels de ces derniers |
| AU742237B2 (en) * | 1998-07-14 | 2001-12-20 | Alcon Manufacturing Limited | Use of 11-(3-dimenthylaminopropylidene)-6,11-dihydrodibenz (B,E)oxepin-2-acetic acid for the manufacture of medicament for treating non-allergic opthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| DE602005015174D1 (de) | 2004-04-21 | 2009-08-13 | Teva Pharma | Verfahren zur herstellung von montelukast-natrium |
| ITMI20050247A1 (it) | 2005-02-18 | 2006-08-19 | Chemi Spa | Processo per la preparazione di montelukast |
| WO2006131782A1 (en) * | 2005-06-07 | 2006-12-14 | Glade Organics Private Limited | Process for the manufacture of methyl-2-(3-(2-(7-chloro-2-quinolinyl-ethenyl)-phenyl)-3-oxopropyl) benzoate |
| CA2608369A1 (en) | 2005-07-05 | 2007-01-11 | Teva Pharmaceutical Industries Ltd. | Purification of montelukast |
| CN101356158B (zh) * | 2005-11-18 | 2011-12-14 | 斯索恩有限公司 | 用于制备孟鲁司特的中间体及相关的化合物 |
| AR057909A1 (es) * | 2005-11-18 | 2007-12-26 | Synthon Bv | Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico. |
| WO2008032099A2 (en) * | 2006-09-15 | 2008-03-20 | Cipla Limited | Process for the preparation of montelukast, and intermediates therefor |
| ES2320077B1 (es) * | 2007-07-31 | 2010-02-26 | Moehs Iberica, S.L. | Proceso de preparacion de un antagonista de leucotrienos y de un intermedio del mismo. |
| CN101851196B (zh) * | 2010-05-28 | 2011-07-27 | 中国科学院昆明植物研究所 | 2-(1h)喹啉酮衍生物,其药物组合物及其制备方法和用途 |
| JP6038914B2 (ja) * | 2011-07-26 | 2016-12-07 | スン プハルマ アドバンセド リサーチ カンパニー リミテド | キノリン−、キノキサリン、又はベンゾチアゾールベースのシステイニルロイコトリエンアンタゴニスト（ｌｔｃ４） |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE59889B1 (en) * | 1986-02-14 | 1994-04-20 | Merck Frosst Canada Inc | 2-substituted quinoline dioic acids |
| IL88433A0 (en) * | 1987-11-25 | 1989-06-30 | Merck Frosst Canada Inc | Diarylstyrylquinoline diacids and pharmaceutical compositions containing them |
| EP0349062A1 (en) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Quinoline ether alkanoic acid |
| NZ233752A (en) * | 1989-05-24 | 1993-05-26 | Merck Frosst Canada Inc | Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof |
-
1992
- 1992-02-17 IE IE049992A patent/IE920499A1/en not_active Application Discontinuation
- 1992-02-18 IL IL100985A patent/IL100985A0/xx unknown
- 1992-02-18 CS CS92471A patent/CS47192A3/cs unknown
- 1992-02-20 DE DE69220517T patent/DE69220517T2/de not_active Expired - Fee Related
- 1992-02-20 AU AU11119/92A patent/AU648385B2/en not_active Ceased
- 1992-02-20 AT AT92301393T patent/ATE154801T1/de not_active IP Right Cessation
- 1992-02-20 EP EP92301393A patent/EP0500360B1/en not_active Expired - Lifetime
- 1992-02-20 FI FI920734A patent/FI920734A/fi not_active Application Discontinuation
- 1992-02-20 KR KR1019920002536A patent/KR920016423A/ko not_active Application Discontinuation
- 1992-02-20 HU HU9200552A patent/HU9200552D0/hu unknown
- 1992-02-20 MX MX9200714A patent/MX9200714A/es unknown
- 1992-02-20 ES ES92301393T patent/ES2104821T3/es not_active Expired - Lifetime
- 1992-02-20 NO NO92920681A patent/NO920681L/no unknown
- 1992-02-20 CN CN92102076A patent/CN1065062A/zh active Pending
- 1992-02-20 ZA ZA921232A patent/ZA921232B/xx unknown
- 1992-02-21 CA CA002061675A patent/CA2061675C/en not_active Expired - Fee Related
- 1992-02-21 JP JP4034632A patent/JPH0788361B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO920681L (no) | 1992-08-24 |
| DE69220517D1 (de) | 1997-07-31 |
| IL100985A0 (en) | 1992-11-15 |
| ZA921232B (en) | 1992-10-28 |
| CS47192A3 (en) | 1992-10-14 |
| HU9200552D0 (en) | 1992-05-28 |
| CA2061675A1 (en) | 1992-08-22 |
| AU648385B2 (en) | 1994-04-21 |
| EP0500360B1 (en) | 1997-06-25 |
| DE69220517T2 (de) | 1997-12-18 |
| FI920734A0 (fi) | 1992-02-20 |
| NO920681D0 (no) | 1992-02-20 |
| CA2061675C (en) | 2002-12-17 |
| FI920734A (fi) | 1992-08-22 |
| AU1111992A (en) | 1992-08-27 |
| JPH0525135A (ja) | 1993-02-02 |
| CN1065062A (zh) | 1992-10-07 |
| ATE154801T1 (de) | 1997-07-15 |
| EP0500360A1 (en) | 1992-08-26 |
| ES2104821T3 (es) | 1997-10-16 |
| JPH0788361B2 (ja) | 1995-09-27 |
| MX9200714A (es) | 1992-10-01 |
| IE920499A1 (en) | 1992-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR920016423A (ko) | 루코트리엔 길항제로서의 퀴놀린-함유 케토산 | |
| KR920008006A (ko) | 류코트리엔 길항제로서의 불포화 하이드록시 알킬퀴놀린산 | |
| PT95389A (pt) | Processo para a preparacao de novos derivados pirazolicos com accao anti-inflamatoria | |
| KR880007460A (ko) | 3-헤테로-치환된-n-벤질-인돌 | |
| KR950702982A (ko) | 치환된 티아졸리딘디온 유도체(Substituted Thiazolidinedione Derivatives) | |
| KR910004600A (ko) | 류코트리엔의 생합성 억제제로서의 (퀴놀린-2-일메톡시)인돌 | |
| ES2137169T3 (es) | Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene. | |
| KR970015578A (ko) | 아릴알킬 디아진온 | |
| KR900018035A (ko) | 디아릴스티릴퀴놀린 이산 | |
| KR900003170A (ko) | 신규 화합물 | |
| KR930006014A (ko) | 삼환식 복소환식 화합물 | |
| KR970706265A (ko) | 아졸 유도체(Azole derivative) | |
| KR870003991A (ko) | 치환된 벤젠 유도체의 제조방법 | |
| KR930701415A (ko) | 약학적으로 활성인 벤조퀴나졸린 화합물 | |
| KR880003920A (ko) | 피리다지논 유도체 | |
| KR940005558A (ko) | 옥심 유도체 | |
| KR940011450A (ko) | 살진균성 2-알콕시-2-이미다졸린-5-온 유도체 | |
| KR920008005A (ko) | 류코트리엔 길항제로서의 하이드록시 알킬퀴놀린 에테르 산 | |
| NO178025C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive (benzhydryloksyetylpiperidyl)alifatiske syrederivater | |
| KR940005621A (ko) | 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도 | |
| KR900006316A (ko) | 벤조 헤테로 고리화합물 및 그 제조방법 | |
| KR927003564A (ko) | 크로몬 유도체 및 이 화합물을 유효성분으로 하는 아르도스 리덕타제 저해제 | |
| KR880012520A (ko) | 류코트리엔 길항제 | |
| KR890009890A (ko) | 하이드록시 피리미딘의 아실 유도체 | |
| KR900701270A (ko) | 피리디닐메틸(술피닐 또는 티오)벤즈이미다졸을 사용한 인체 눈의 녹내장 및 관련 장해의 치료 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |